Table of Contents
ISRN Hematology
Volume 2012, Article ID 839242, 7 pages
http://dx.doi.org/10.5402/2012/839242
Clinical Study

The Platelet Function Analyzer (PFA-100) as a Screening Tool in Neurosurgery

1Medizinische Fakultät, Philipps-Universität Marburg, Conradistraße, 35043 Marburg, Germany
2Praxis für Transfusionsmedizin, Aachener Straße 313, 50931 Köln, Germany
3Klinik für Neurochirurgie, Philipps-Universität Marburg, Conradistraße, 35043 Marburg, Germany
4Klinik für Neurochirurgie, Universitätsklinikum Essen, Hufelandstraße 55, 45147 Essen, Germany

Received 18 April 2012; Accepted 18 June 2012

Academic Editors: A. Bosly, K. L. Dikshit, I. C. Haznedaroglu, and J. Yu

Copyright © 2012 Ralf Karger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Palmer, O. C. Sparrow, F. Iannotti, N. H. Horwitz, and J. T. Hoff, “Postoperative hematoma: a 5-year survey and identification of avoidable risk factors,” Neurosurgery, vol. 35, no. 6, pp. 1061–1065, 1994. View at Google Scholar · View at Scopus
  2. W. A. S. Taylor, N. W. M. Thomas, J. A. Wellings, and B. A. Bell, “Timing of postoperative intracranial hematoma development and implications for the best use of neurosurgical intensive care,” Journal of Neurosurgery, vol. 82, no. 1, pp. 48–50, 1995. View at Google Scholar · View at Scopus
  3. M. F. Chernov and P. I. Ivanov, “Urgent reoperation for major regional complications after removal of intracranial tumors: outcome and prognostic factors in 100 consecutive cases,” Neurologia Medico-Chirurgica, vol. 47, no. 6, pp. 243–248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Serious Hazards of Transfusion (SHOT), 2011, http://www.shotuk.org/.
  5. E. Seifried, H. Klueter, C. Weidmann et al., “How much blood is needed?” Vox Sanguinis, vol. 100, no. 1, pp. 10–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Koscielny, S. Ziemer, H. Radtke et al., “A practical concept for preoperative identification of patients with impaired primary hemostasis,” Clinical and Applied Thrombosis/Hemostasis, vol. 10, no. 3, pp. 195–204, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Harrison, “The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults,” British Journal of Haematology, vol. 130, no. 1, pp. 3–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. B. Segal, W. H. Dzik, and Medicine/Hemostasis Clinical Trials Network, “Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review,” Transfusion, vol. 45, no. 9, pp. 1413–1425, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. R. E. Scharf, “Acquired platelet function defects: an underestimated but frequent cause of bleeding complications in clinical practice,” in Progress and Challenges in Transfusion Medicine, Hemostasis, and Hemotherapy, R. E. Scharf, Ed., pp. 296–316, Karger, Freiburg, Germany, 2008. View at Google Scholar
  10. P. Peterson, T. E. Hayes, C. F. Arkin et al., “The preoperative bleeding time test lacks clinical benefit: college of American Pathologists' and American society of clinical pathologists' position article,” Archives of Surgery, vol. 133, no. 2, pp. 134–139, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. M. A. A. Kratzer and G. V. R. Born, “Simulation of primary haemostasis in vitro,” Haemostasis, vol. 15, no. 6, pp. 357–362, 1985. View at Google Scholar · View at Scopus
  12. V. Kretschmer and M. Weippert-Kretschmer, “Determination and treatment of disorders of primary haemostasis: experience with routine application of the in vitro bleeding test,” Hamostaseologie, vol. 19, no. 4, pp. 168–175, 1999. View at Google Scholar · View at Scopus
  13. R. Karger, N. Donner-Banzhoff, H. H. Müller, V. Kretschmer, and M. Hunink, “Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history—a systematic review and meta-analysis,” Platelets, vol. 18, no. 4, pp. 249–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Franchini, “The platelet-function analyzer (PFA-100) for evaluating primary hemostasis,” Hematology, vol. 10, no. 3, pp. 177–181, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. P. M. Mannucci, “Treatment of von Willebrand's disease,” The New England Journal of Medicine, vol. 351, no. 7, pp. 683–730, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Franchini, “The use of desmopressin as a hemostatic agent: a concise review,” American Journal of Hematology, vol. 82, no. 8, pp. 822–825, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. P. A. Carless, D. A. Henry, A. J. Moxey et al., “Desmopressin for minimising perioperative allogeneic blood transfusion,” Cochrane Database of Systematic Reviews (Online), no. 1, article CD001884, 2004. View at Google Scholar · View at Scopus
  18. J. E. Beshay, H. Morgan, C. Madden, W. Yu, and R. Sarode, “Emergency reversal of anticoagulation and antiplatelet therapies in neurosurgical patients: a review,” Journal of Neurosurgery, vol. 112, no. 2, pp. 307–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Y. Tse, W. Y. Cheung, K. F. Ng, and K. D. Luk, “Reducing perioperative blood loss and allogeneic blood transfusion in patients undergoing major spine surgery,” Journal of Bone and Joint Surgery, American Volume, vol. 93, no. 13, pp. 1268–1277, 2011. View at Google Scholar
  20. S. K. Kundu, E. J. Heilmann, R. Sio, C. Garcia, R. M. Davidson, and R. A. Ostgaard, “Description of an in vitro platelet function analyzer—PFA-100,” Seminars in Thrombosis and Hemostasis, vol. 21, no. 2, supplement, pp. 106–112, 1995. View at Google Scholar · View at Scopus
  21. P. Harrison, “In vitro measurement of high-shear platelet adhesion and aggregation by the PFA-100,” Methods in Molecular Biology, vol. 272, pp. 215–223, 2004. View at Google Scholar · View at Scopus
  22. J. L. Francis, “Platelet Function Analyzer (PFA)-100,” in Platelets, A. Michelson, Ed., pp. 325–335, Academic Press, San Diego, Calif, USA, 2002. View at Google Scholar
  23. I. P. Zupan, M. Sabovic, B. Salobir et al., “The study of anaemia-related haemostasis impairment in haemodialysis patients by in vitro closure time test,” Thrombosis and Haemostasis, vol. 93, no. 2, pp. 375–379, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. C. R. Valeri, G. Cassidy, L. E. Pivacek et al., “Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss,” Transfusion, vol. 41, no. 8, pp. 977–983, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., “The 2007 WHO classification of tumours of the central nervous system,” Acta Neuropathologica, vol. 114, no. 2, pp. 97–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Teasdale and B. Jennett, “Assessment of coma and impaired consciousness. A practical scale,” The Lancet, vol. 2, no. 7872, pp. 81–84, 1974. View at Google Scholar · View at Scopus
  27. B. Jennett and M. Bond, “Assessment of outcome after severe brain damage. A practical scale,” The Lancet, vol. 1, no. 7905, pp. 480–484, 1975. View at Google Scholar · View at Scopus
  28. A. Vakili, H. Kataoka, and N. Plesnila, “Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 25, no. 8, pp. 1012–1019, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Trabold, S. Krieg, K. Schöller, and N. Plesnila, “Role of vasopressin V1a and V2 receptors for the development of secondary brain damage after traumatic brain injury in mice,” Journal of Neurotrauma, vol. 25, no. 12, pp. 1459–1465, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Kretschmer, B. Schikor, D. Söhngen, and G. Dietrich, “In vitro bleeding test—a simple method for the detection of aspirin effects on platelet function,” Thrombosis Research, vol. 56, no. 5, pp. 593–602, 1989. View at Publisher · View at Google Scholar · View at Scopus
  31. W. Burger, J. M. Chemnitius, G. D. Kneissl, and G. Rücker, “Low-close aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation—review and meta-analysis,” Journal of Internal Medicine, vol. 257, no. 5, pp. 399–414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. P. G. Chassot, C. Marcucci, A. Delabays, and D. R. Spahn, “Perioperative antiplatelet therapy,” American Family Physician, vol. 82, no. 12, pp. 1484–1489, 2010. View at Google Scholar · View at Scopus
  33. R. A. Cahill, G. T. McGreal, B. H. Crowe et al., “Duration of increased bleeding tendency after cessation of aspirin therapy,” Journal of the American College of Surgeons, vol. 200, no. 4, pp. 564–573, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. P. G. Campbell, A. Sen, S. Yadla, P. Jabbour, and J. Jallo, “Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review,” World Neurosurgery, vol. 74, no. 2-3, pp. 279–285, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Sawaya, O. J. Ramo, M. L. Shi, and G. Mandybur, “Biological significance of tissue plasminogen activator content in brain tumors,” Journal of Neurosurgery, vol. 74, no. 3, pp. 480–486, 1991. View at Google Scholar · View at Scopus
  36. Y. Buyukasik, S. Karakus, H. Goker et al., “Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease,” Blood Coagulation and Fibrinolysis, vol. 13, no. 4, pp. 349–353, 2002. View at Publisher · View at Google Scholar · View at Scopus